Clinical Trial Update: Study to Assess the Safety and Effects of Autologous Adipose-Derived SVF Cells in Patients With Parkinson's Disease [NA]

View source ↗

Summary

The study evaluating autologous adipose-derived stromal vascular fraction (SVF) cells for Parkinson's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Autologous adipose-derived stromal vascular fraction (SVF) cells

Snippet

Sponsor: Ageless Regenerative Institute | Conditions: Parkinson's Disease | NA | Status: WITHDRAWN